Skip to main content
. 2016 Jan 13;6:19150. doi: 10.1038/srep19150

Table 1. Baseline characteristics of the dialysis patients with or without parathyroidectomy (PTx) at the time of undergoing radionuclide parathyroid scanning, before and after being matched on propensity score.

  Before matching
After matching
Overall (n = 2786) PTx (n = 1707) Control (n = 1079) PTx (n = 998) Control (n = 998) Standardized difference§
Age (years) 54.0 ± 12.5 52.9 ± 11.9 55.8 ± 13.4 54.7 ± 11.8 55.0 ± 13.1 0.02
Male sex (%) 1131(40.6) 676 (39.6) 455 (42.2) 428 (42.9) 424 (42.5) 0.01
HD (%) 2548 (91.5) 1577 (92.4) 971 (90.0) 902 (90.4) 903 (90.5) <0.01
Dialysis duration (years) 4.61 ± 2.98 4.90 ± 2.93 4.14 ± 3.00 4.24 ± 2.78 4.31 ± 2.99 0.02
DM (%) 604 (21.7) 346 (20.3) 258 (23.9) 244 (24.5) 219 (21.9) 0.06
Hypertension (%) 1434 (51.5) 859 (50.3) 575 (53.3) 539 (54.0) 518 (51.9) 0.04
Hyperlipidemia (%) 680 (24.4) 439 (25.7) 241 (22.3) 279 (28.0) 213 (21.3) 0.15
AMI (%) 71 (2.6) 32 (1.9) 39 (3.6) 24 (2.4) 29 (2.9) 0.03
CAD (%) 396 (14.2) 234 (13.7) 162 (15.0) 173 (17.3) 137 (13.7) 0.10
CHF (%) 448 (16.1) 244 (14.3) 204 (18.9) 179 (17.9) 181 (18.1) 0.01
Arrhythmia (%) 327 (11.7) 184 (10.8) 143 (13.3) 134 (13.4) 124 (12.4) 0.03
PVD (%) 399 (14.3) 258 (15.1) 141 (13.1) 167 (16.7) 125 (12.5) 0.12
CVA (%) 308 (11.1) 177 (10.4) 131 (12.1) 134 (13.4) 118 (11.8) 0.05
Anemia (%) 463 (16.6) 233 (13.7) 230 (21.3) 179 (17.9) 184 (18.4) 0.01
COPD (%) 282 (10.1) 154 (9.0) 128 (11.9) 97 (9.7) 116 (11.6) 0.06
GI bleeding (%) 725 (26.0) 476 (27.9) 249 (23.1) 302 (30.3) 232 (23.3) 0.16
Liver disease (%) 558 (20.0) 339 (19.9) 219 (20.3) 212 (21.2) 189 (18.9) 0.06
Dementia (%) 33 (1.2) 14 (0.8) 19 (1.8) 13 (1.3) 14 (1.4) 0.01

Abbreviations: HD, hemodialysis; DM, diabetes mellitus; AMI, acute myocardial infarction; CAD, coronary artery disease; CHF, congestive heart failure; PVD, peripheral vascular disease; CVA, cerebral vascular accident, COPD, chronic obstructive pulmonary disease; GI bleeding, gastrointestinal bleeding; PTx, parathyroidectomy.

§Standardized difference = difference in proportions or means divided by a pooled estimate of standard deviation.

May only indicate resistance of erythropoiesis-stimulating agents and/or requirement of blood transfusion (supplementary information).